Krystal Biotech (KRYS) has drawn fresh attention after reporting positive interim data from the highest dose cohort of its ...
Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 millionRobust clinical pipeline with multibillion dollar opportunities and strong ...
Krystal Biotech (NASDAQ:KRYS) said it has generated positive interim clinical results for its inhaled cystic fibrosis (CF) ...
Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutationsKB407 transduction confirmed in all ...
Southeastern slider chain Krystal has filed for Chapter 11 bankruptcy protection, citing debts of as much as $100 million. "The actions we are taking are intended to enable Krystal to establish a ...
Krystal, the original home of the slider in the South, is ringing in the New Year with bold flavors that don’t break the bank. With the return of the $4.99 Krystal Meal Deal, a spotlight on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results